Introduction {#sec1}
============

Programmed cell death (PCD) plays an important role in sculpting tissues during animal development ([@bib1; @bib8]). The molecular regulators that are central to this process seem to be evolutionarily conserved from worms to mammals ([@bib8; @bib16]) and include autocatalytic initiator caspases, *trans*-activable effector caspases, cytosolic activating factors (APAF-1), and multidomain Bcl-2 proteins ([@bib8; @bib16]). The proapoptotic Bcl-2-family proteins oligomerize and permeabilize mitochondria, releasing intermembrane space components such as cytochrome-C and Smac/DIABLO into the cytosol, where they activate initiator caspases by an ATP-dependent mechanism ([@bib8]). Initiator caspases *trans*-activate effector caspases that cleave multiple cellular substrates, resulting in DNA degradation, nuclear condensation, and loss of cell integrity ([@bib8; @bib38]).

Mitochondrial outer-membrane permeabilization has been proposed to depend on the mitochondrial fission and fusion machinery ([@bib29; @bib41]). Consistent with this, mitochondria undergo dramatic fragmentation very close in time to cytochrome-C release during mammalian cell death ([@bib11; @bib22]). Furthermore, an increase in mitochondrial fragmentation and a block in mitochondrial fusion are essential for cell death progression ([@bib11; @bib18; @bib42]). In normal cells, the balance in the rates of mitochondrial fission and fusion regulated by Dynamin-related protein-1 (Drp-1), Fis-1 and endophilin (fission), or Mitofusins and Opa-1 (fusion) maintains the dynamic, interconnected mitochondrial tubules ([@bib24; @bib27; @bib39]). An increase in recruitment of Drp-1 to the mitochondria accentuates staurosporine, lipid, and free oxygen radical stress-induced mitochondrial outer-membrane permeabilization ([@bib4; @bib34]). Moreover, multiple apoptotic stimuli induce mitochondrial recruitment of the proapoptotic Bcl-2-family protein, Bax, to Drp-1 and Mitofusin-2-positive putative mitochondrial fragmentation sites ([@bib18; @bib26]) in a Fis-1-dependent manner ([@bib21]), consistent with a role for mitochondrial fission and fusion machinery in cell death.

In *Drosophila*, RHG-family proteins ([@bib31]), genotoxic stresses, and protein synthesis inhibitors ([@bib5; @bib43]) antagonize *Drosophila* inhibitor of apoptosis protein-1 (DIAP-1)-mediated inhibition of the activation of the apical caspase Dronc in an ARK- (*Drosphila* APAF-1) and ATP-dependent manner ([@bib25]), leading to effector caspase activation and cell death. The role of mitochondria in this process is unclear. Cytochrome-C has been shown to be differentially displayed from the mitochondria during cell death ([@bib35]). Knockdown of *Drosophila* cytochrome-C did not affect cell death triggered by genotoxic stress in vitro ([@bib23]) and ex vivo ([@bib43]) or developmental stimuli in vivo ([@bib10]), although certain nonapoptotic caspase activation pathways utilized during sperm individualization were affected ([@bib2]). Furthermore, mitochondrial morphology during *Drosophila* PCD has not been previously reported.

In this study, we show that multiple apoptotic stimuli result in mitochondrial fragmentation upstream of caspase activation, phosphatidylserine exposure, and nuclear condensation in *Drosophila* cells. While etoposide induced mitochondrial fragmentation, C~6~-ceramide resulted in an increase in mitochondrial contiguity prior to its fragmentation. *drp-1* mutant or RNAi-treated S2R^+^ cells are considerably protected from multiple apoptotic stimuli, consistent with reduced mitochondrial fragmentation. Thus, mitochondrial remodeling plays an important role in modifying the propensity of cells to undergo PCD in *Drosophila*.

Results {#sec2}
=======

Mitochondria Undergo Fragmentation during PCD in *Drosophila* {#sec2.1}
-------------------------------------------------------------

Precisely timed ecdysone pulses induce Reaper and Hid expression in the *Drosophila* larval midgut (0 hr after puparium formation \[APF\]) or the salivary gland (10 hr APF) and trigger developmental PCD ([@bib40]). Mitochondria, visualized by using matrix-targeted GFP (Mito-GFP) ([@bib30]) in acridine orange-positive, dying prepupal midgut cells (1 hr APF, [Figure 1](#fig1){ref-type="fig"}Aiii) and salivary glands (4 hr APF, [Figure 1](#fig1){ref-type="fig"}Biii), were remarkably fragmented, unlike third-instar larval (−4 hr APF) mitochondria. Quantification revealed a dramatic decrease in the prepupal mitochondrial cross-sectional area (CSA; midgut \[∼0.7 μm^2^ from ∼1.4 μm^2^, [Figure 1](#fig1){ref-type="fig"}A\] and salivary gland \[[Figure S1](#app2){ref-type="sec"}A, see the [Supplemental Data](#app2){ref-type="sec"} available with this article online\]) and a significant increase in the number of mitochondria per cell ([Figure S1](#app2){ref-type="sec"}A). Moreover, ecdysone-induced mitochondrial fragmentation was mimicked ex vivo on third-instar larval wing discs by using 1 mM ecdysone ([@bib19]) for 2 hr ([Figure 1](#fig1){ref-type="fig"}C; [Figure S1](#app2){ref-type="sec"}B). In addition, overexpression of Hid resulted in mitochondrial fragmentation in acridine orange-positive eye disc cells ([Figure S1](#app2){ref-type="sec"}C). Thus, mitochondria in *Drosophila* tissues fragment during PCD, as has been reported in *C*. *elegans* ([@bib17]) and mammalian cells ([@bib11]).

Multiple Apoptotic Stimuli Trigger Distinct Mitochondrial Remodeling Events during Cell Death {#sec2.2}
---------------------------------------------------------------------------------------------

To assess the role of mitochondrial remodeling in PCD, mitochondrial morphology was temporally characterized in etoposide-, actinomycin-D-, cycloheximide-, or C~6~-ceramide (a lipid cell death mediator)-treated ([@bib37]) larval hemocytes ([@bib33]) and the S2R^+^ cell line. A 3- to 4-fold increase in nuclear condensation (6 hr, [Figure 1](#fig1){ref-type="fig"}H) was preceded by effector caspase activation (5 hr, [Figures 2](#fig2){ref-type="fig"}A--2Biv) and phosphatidylserine (PS) exposure in propidium iodide (PI)-negative hemocytes (6 hr, [Figures 2](#fig2){ref-type="fig"}A--2Bv). These cells subsequently (10 hr) became characteristically blebbed ([Figures 2](#fig2){ref-type="fig"}A--2Bvi) and PI permeable ([Figures 1](#fig1){ref-type="fig"}D--1Eiv, top inset). The number of etoposide-treated apoptotic hemocytes increased with time ([Figure 1](#fig1){ref-type="fig"}G). Interestingly, mitochondrial fragmentation ([Figures 1](#fig1){ref-type="fig"}Dii and 1G), as confirmed by quantifying functionally isolated mitochondria ([Figure S2](#app2){ref-type="sec"} and [Movie S1](#app2){ref-type="sec"}) ([@bib7]) at 3 hr, preceded the onset of PS exposure ([Figure 2](#fig2){ref-type="fig"}Av) or nuclear damage ([Figures 1](#fig1){ref-type="fig"}G and 1H). Quantification showed an increase in the number of mitochondria and the contribution of fragmented mitochondria to the mitochondrial CSA ([Figures S3](#app2){ref-type="sec"}B, S3D, and S3E). Mitochondrial fragmentation was also observed in cycloheximide- or actinomycin-D-treated, Mito-YFP-transfected S2R^+^ cells (6 hr, [Figures S3](#app2){ref-type="sec"}G and [S3](#app2){ref-type="sec"}H).

Surprisingly, mitochondria in C~6~-ceramide-treated (30--60 min) hemocytes that had normal nuclei were highly contiguous (open arrowheads, [Figure 1](#fig1){ref-type="fig"}Eii). Quantifying functionally isolated mitochondrial CSA per cell showed a significant increase in the contribution of tubular or extensively tubular mitochondria in these cells when compared with untreated cells ([Figure S3](#app2){ref-type="sec"}F). However, by 4 hr, these extensively tubular mitochondria underwent fragmentation in FITC-Annexin V (AnV)-negative hemocytes that had normal nuclei ([Figures 1](#fig1){ref-type="fig"}Eiii and 1I), similar to what was observed with genotoxic stress ([Figure 1](#fig1){ref-type="fig"}Dii).

Therefore, genotoxic stresses triggered mitochondrial fragmentation, while the lipid cell death mediator induced increased mitochondrial contiguity and subsequent fragmentation prior to PS exposure, nuclear condensation, and finally plasma membrane permeability during *Drosophila* cell death.

Mitochondrial Fragmentation Is Upstream of Effector Caspase Activation {#sec2.3}
----------------------------------------------------------------------

In hemocytes incubated with an apoptotic stimulus, mitochondrial fragmentation (3--4 hr) preceded any detectable effector caspase activation (5 hr \[[Figures 2](#fig2){ref-type="fig"}A and 2Biv\]). Furthermore, inhibiting caspases with zVAD-fmk or by overexpressing *DIAP-1* (*DIAP-1*+) ([@bib15]) did not affect mitochondrial fragmentation ([Figure 2](#fig2){ref-type="fig"}C), although hemocyte death was inhibited ([Figures 2](#fig2){ref-type="fig"}F--2H), as revealed by a lack of apoptotic markers ([Figures 2](#fig2){ref-type="fig"}D and 2E; zVAD-fmk; data not shown). In addition, overexpression of *Dcp-1*, a *Drosophila* effector caspase, did not affect mitochondrial morphology ([Figure S4](#app2){ref-type="sec"}). Thus, mitochondrial fragmentation is upstream of effector caspase activation.

Mitochondrial Morphology Is Extensively Tubular in *drp-1* Mutants {#sec2.4}
------------------------------------------------------------------

The *drp-1* mutants used to study the role of mitochondrial remodeling during *Drosophila* PCD are functional null alleles, *drp-1*^2^ (Gly293Ser mutation), picked in a forward screen for genes affecting neurotransmission and *drp-1*^\[KG\ 03815\]^, a P element insertion between the first two exons of *drp-1* (*13510* in this study) and a hypomorph, *nrd*^D46^ (Arg278Trp mutation; *3665* in this study) ([@bib32; @bib36]). *drp-1*^2^, *13510*, and the deficiency Df Exel6008 were second-instar larval lethal (data not shown); however, *drp-1*^2^ yielded bang-sensitive escapers ([@bib36]). The hypomorphic *trans*-allelic combination of *3665/13510* was third-instar larval lethal, although it yielded a few temperature-sensitive adults ([@bib32]). A genomic duplication of *drp-1* (Dp \[2;1\] JS13 \[[@bib32]\]) completely rescued the lethality associated with *drp-1*^2^, *13510*, and *3665/13510*.

Mitochondria in *drp-1*^2^ and *3665/13510* hemocytes were extensively tubular when compared with wild-type mitochondria (open arrowheads, [Figures 3](#fig3){ref-type="fig"}Bi--3Biii). Quantifying mitochondrial morphology revealed a 2-fold decrease in the number of mitochondria and a significant increase in the contribution of tubular and extensively tubular mitochondria to the total mitochondrial CSA in *drp-1* mutant hemocytes when compared with wild-type cells ([Figure S5](#app2){ref-type="sec"}). Interestingly, *13510/+* hemocytes ([Figures 3](#fig3){ref-type="fig"}Biv and 3Ci) or eye disc cells ([Figure S5](#app2){ref-type="sec"}) displayed a dominant mitochondrial fission defect that was completely rescued by a genomic duplication of *drp-1* ([Figure 3](#fig3){ref-type="fig"}Cii). The mitochondrial fission defect in mutant cells could result from a reduced mitochondrial association of Drp-1 ([Figure S6](#app2){ref-type="sec"}).

An increase in mitochondrial contiguity due to a loss of Drp-1 function was also confirmed by measuring fluorescence recovery after photobleaching (FRAP) of Mito-YFP ([@bib7]) in *drp-1* RNAi-treated S2R^+^ cells that had extensively tubular mitochondria ([Figure 3](#fig3){ref-type="fig"}D). Relative FRAP of Mito-YFP in a defined mitochondrial region in *drp-1* RNAi-treated cells was significantly (p \< 0.01) higher than that observed in mock RNAi-treated cells ([Figure 3](#fig3){ref-type="fig"}F).

Drp-1-Mediated Fragmentation of Mitochondria Affects PCD {#sec2.5}
--------------------------------------------------------

*drp-1* mutant hemocytes were protected from etoposide-induced death up to at least 10 hr ([Figures 4](#fig4){ref-type="fig"}A and 4B), as revealed by a lack of caspase activation, PS exposure, or PI permeability in the majority (∼80%) of these cells ([Figures 4](#fig4){ref-type="fig"}Fi, 4Fii, 4Fv, and 4Fvi). Furthermore, *drp-1* mutant and dsRNA-treated S2R^+^ cells were significantly protected (p \< 0.01) from cycloheximide-, actinomycin-D- ([Figures 4](#fig4){ref-type="fig"}C and 4D), or UV-B-induced ([Figure S7](#app2){ref-type="sec"}) death. Consistent with increased protection, mitochondria in the majority (∼98%) of etoposide-treated *drp-1*^2^ hemocytes failed to fragment (6 hr; compare [Figure 4](#fig4){ref-type="fig"}Gii with [Figure 4](#fig4){ref-type="fig"}Gi). Interestingly, mitochondria in etoposide-treated *3665/13510* hemocytes revealed a tubular, yet beaded and swollen intermediate in mitochondrial fragmentation by 4 hr ([Figure 4](#fig4){ref-type="fig"}Giii) that yielded some fragmented mitochondria in few (∼25%) cells later (6 hr; data not shown). Therefore, reduced (*drp-1*^2^) or delayed (*3665/13510*) mitochondrial fragmentation decreased effector caspase activation and protected cells from genotoxic stress. Moreover, an increase in expression of Drp-1 in hemocytes resulted in enhancement of etoposide-induced cell death ([Figure S8](#app2){ref-type="sec"}).

The majority (∼70%) of the C~6~-ceramide-treated *drp-1*^2^ hemocytes did not show effector caspase activation or PS exposure and displayed significant (p \< 0.05) protection ([Figures 4](#fig4){ref-type="fig"}E, 4Fiii, and 4Fvii), similar to what was observed with etoposide, although hemocytes derived from the weaker allelic combination, *13510/3665*, were apoptotic ([Figures 4](#fig4){ref-type="fig"}Fiv and 4Fviii). Unlike *13510/3665* mitochondria, *drp-1*^2^ mitochondria failed to fragment ([Figure 4](#fig4){ref-type="fig"}Hi), consistent with an essential role for Drp-1-mediated mitochondrial fragmentation during apoptosis in *Drosophila*. Moreover, developmental PCD in *drp-1*^2^ mutant larvae was considerably reduced, as revealed by the enlarged central nervous system and a prominently elongated ventral ganglion ([Figure 4](#fig4){ref-type="fig"}I), similar to other PCD-defective mutants reported ([@bib25]).

Discussion {#sec3}
==========

During metamorphosis, the first ecdysone pulse triggers mitochondrial fragmentation in prepupal tissues, although it is after the second ecdysone pulse that salivary gland histolysis occurs. It is likely that DIAP-1 inhibits caspases in these cells that have fragmented mitochondria until it is downregulated at the transcriptional level or degraded after the second ecdysone pulse ([@bib40]). Interestingly, this was mimicked ex vivo in etoposide-treated *DIAP-1*+ hemocytes.

The data presented here show involvement of mitochondrial fragmentation for ARK-mediated Dronc activation during cell death. The RHG-family proteins that localize to the mitochondria ([@bib6; @bib14; @bib28]) might activate Drp-1-mediated mitochondrial fragmentation. This could result in exposure of cytochrome-C ([@bib35]) or release of Peanut ([@bib13]), which antagonize DIAP-1-mediated suppression of Dronc. However, as *Drosophila* PCD was unaffected upon knockdown of cytochrome-C ([@bib10]), mitochondrial fragmentation in *Drosophila* and mammalian cells would increase mitochondrial surface area and perhaps the concentration of bulky head group lipids on the outer mitochondrial membrane, facilitating recruitment of proapoptotic proteins. Drp-1 might organize sites for *Drosophila* Bcl-2-family protein Debcl function on mitochondria ([@bib9]) that are similar to mitochondrial sites of Bax recruitment in mammalian cells ([@bib18]).

These results provide the first, to our knowledge, evidence that Drp-1-mediated mitochondrial fragmentation upstream of effector caspase activation modifies apoptotic sensitivity ([Figure 4](#fig4){ref-type="fig"}J). Thus, mitochondrial fragmentation, like caspase activation, plays a conserved and unifying role in diverse cell death pathways from worms to mammals ([@bib11; @bib17]). Although the function of the highly contiguous mitochondria during lipid-induced cell death remains poorly understood, this study brings to the forefront a modulatory role for mitochondrial remodeling in determining the susceptibility of *Drosophila* cells to death.

Experimental Procedures {#sec4}
=======================

Materials {#sec4.1}
---------

Media and chemicals were obtained from GIBCO-BRL or Sigma-Aldrich unless otherwise specified. Fluorescent dyes for tagging and Mitotracker dyes were purchased from Molecular Probes. Secondary antibodies (Jackson ImmunoResearch Laboratories) were conjugated to fluorescent dyes as recommended by the manufacturer.

*Drosophila* Stocks {#sec4.2}
-------------------

*Drosophila* stocks were grown at 25°C in cornmeal agar bottles. *drp-1* mutants, Collagen-GAL4, and UAS-Mito-GFP were kindly provided by Hugo J. Bellen (Baylor College of Medicine, TX), K.S. Krishnan (DBS, TIFR, Mumbai), Charles R. Dearolf (Duke University, NC), and William Saxton (Indiana University, IN).

Treatment of Tissues and Cells Ex Vivo {#sec4.3}
--------------------------------------

Third-instar larval tissues were dissected in Schneider insect medium supplemented with 10% non-heat-inactivated fetal bovine serum and 1 μg/ml bovine pancreatic insulin (SCM). They were washed in 1× PBS (pH 7.4) and incubated with 1 mM water-soluble ecdysone (AG Scientific, Inc.) diluted in PBS for 2 hr (20°C), fixed with 4% formaldehyde (30 min), permeabilized with 0.37% Igepal (13 min), and labeled with Alexa 568 Phalloidin (1:200; Molecular Probes) for 30 min. The tissues were mounted beneath a coverslip and imaged. Mitochondria were selected based on a threshold and were quantified by using Metamorph (Molecular Devices Corporation).

Hemocytes derived from late third-instar larvae and S2R^+^ cells were plated in 35 mm coverslip-bottom dishes. Hemocytes at ∼1 hr postdissection were incubated with etoposide (10 μM), cycloheximide (0.5 μg/ml), or C~6~-ceramide (20 μM or 40 μM; Matreya, Inc.) diluted in 1× Medium 1 (M1) supplemented with 2 mg/ml glucose (imaging medium \[IM\]) at 20°C for the indicated times prior to staining nuclei with 5 μg/ml Hoechst-33342 (5 min). Hemocytes were preincubated (30 min) with 50 μM Caspase inhibitor-1 (zVAD-fmk; Calbiochem) in IM before incubation with apoptotic stimuli in the presence of 50 μM zVAD-fmk in order to inhibit caspases. Immunofluorescence staining was carried out as described earlier ([@bib33]), by using affinity-purified rabbit anti-Drp-1 antibody (1:200), mouse Biotin antibody (1:500), and appropriate secondary antibodies (1:500). Drp-1 punctae were selected by using a threshold on background corrected images and were quantified.

A total of 1 × 10^6^ S2R^+^ cells were cotransfected with 1 μg siRNAi (Dharmacon, Inc.) and 0.25 μg pAVW vector (expressing EYFP only) (*Drosophila* Genomics Resource Centre, Indiana University), by using Cellfectin transfection reagent (Invitrogen). After 5 days, cells were treated with prescribed concentrations of actinomycin-D or cycloheximide for 18 hr, and surviving YFP-expressing cells in five randomly selected fields were counted (n = 5; total cells = 14,020). Counts were normalized to the untreated control; error bars represent standard error of the mean for normalized data.

Detection of Active Caspases and PI, AnV Staining {#sec4.4}
-------------------------------------------------

Hemocytes were incubated with 10 μM caspACE substrate (FITC-VAD-FMK, Promega) for 20 min (20°C) or stained with PI (20 μg/ml), AnV (2 μg/ml) (Santa Cruz Biotechnology), and Hoechst-33342 (5 μg/ml) diluted in M1 supplemented with 2.5 mM calcium chloride and 2 mg/ml glucose (20 min) and were imaged.

Imaging {#sec4.5}
-------

Tissues and cell cultures in 35 mm coverslip-bottom dishes were imaged by using 60× or 100×, 1.4 NA, oil-emersion objectives on a Nikon TE 2000-U epi-fluorescent inverted microscope with optimized dichroics and filters and a Cascade 512B EM-CCD camera (Photometrics) controlled by Metamorph (Molecular Devices Corporation). Confocal images were acquired by using either a 60×, 1.4 NA or a 100×, 1.45 NA objective on a Biorad MRC 1024 or Zeiss LSM 510 (Carl Zeiss MicroImaging, Inc.) microscope equipped with optimized dichroics and filters. Images were processed by using Metamorph (Molecular Devices Corporation) and Adobe Photoshop software.

Mitochondrial Morphology {#sec4.6}
------------------------

Tubulin-GAL4 or Collagen-GAL4 was used to express Mito-GFP in multiple tissues by using the GAL4-UAS system ([@bib3]). Hemocytes were incubated with 100 nM Mitotracker diluted in IM supplemented with 1.5 mg/ml BSA (IM+BSA) for 20 min (20°C) and were imaged. S2R^+^ cells were grown in Schneider\'s medium supplemented with 10% fetal bovine serum (Gemini Bio-Products) at 25°C. A total of 1 × 10^6^ cells were plated and transfected with 1 μg EYFP-Mito vector ([@bib20]) by using 5 μl Cellfectin transfection reagent (Invitrogen). Mitochondria were selected by using defined thresholds post background correction and were quantified by using Metamorph (Molecular Devices Corporation).

UV-B Induced Apoptosis in *Drosophila* Third-Instar Larvae {#sec4.7}
----------------------------------------------------------

Third-instar larvae were exposed (90 s) on a dual intensity transilluminator (TM20; UVP, Inc.) fitted with 6 UV-B tubes (20W × 6). A total of 6 hr later, wing discs were dissected and stained with 3 μg/ml acridine orange in PBS (5 min), washed, and imaged on the confocal microscope.

TMRM Fluorescence-Loss Assay {#sec4.8}
----------------------------

Hemocytes were incubated with 10 nM TMRM diluted in SCM or IM+BSA (15 min) and were exposed to 555 nm wavelength light on a wide-field microscope. Time-lapse images (0.2 s) were acquired every 1 s until TMRM was released from all the mitochondria. Individual mitochondria were outlined and quantified by using Metamorph (Molecular Devices Corporation) (n = 5--10).

FRAP Assay {#sec4.9}
----------

S2R^+^ cells that were cotransfected with 1 μg siRNAi (Dharmacon, Inc.) and 1 μg EYFP-Mito by using Cellfectin transfection reagent (Invitrogen) according to the manufacturer\'s instructions were analyzed 5 days posttransfection. Drp siRNA was targeted to 5′-ACACTCCGGTTCACAATAA-3′ (NM_134850 bases 1994--2012), and siCONTROL nontargeting siRNA \#1 (Dharmacon, Inc.) was used as a control. For FRAP, a mitochondrial region of interest (ROI, ∼1.75 μm in diameter) was selected and bleached (after 4 s, indicated by a solid bar) with high-intensity 488 nm wavelength light (∼1 s), and fluorescence in the ROI was measured for an additional 25 s.

RT-PCR {#sec4.10}
------

RNA was extracted from transfected S2R^+^ cells by using the RNeasy Mini Kit (QIAGEN), and RT-PCR was conducted by using the QIAGEN OneStep RT-PCR kit (QIAGEN). The Drp-specific 5′ primer 5′-TCATTCACGAGGAGATGCAG-3′ (designed to NM_134850 bases 1298--1317) and the 3′ primer 5′-TGCTTGGTGTTGATGTAGGC-3′ (designed to NM_134850 bases 1490--1509) were used to amplify a 208 bp product. Ribosomal protein 49 (rp49) primers (5′-ATGACCATCCGCCCAGCATAC-3′ and 5′-GAGAACGCAGGCGACCGTTGG-3′) amplified a 391 bp fragment between bases 1 and 391 of the coding region (GenBank accession number Y13939) ([@bib12]).

Supplemental Data {#app2}
=================
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![Mitochondria Underwent Fragmentation during PCD\
(A--C) (i) Regions (red squares) of *Drosophila* third-instar larval (A) midgut, (B) salivary gland, or (C) wing imaginal disc that were imaged. (A) Mitochondria in (ii) Mito-GFP larval and (iii) prepupal midgut cells (outlined) with the average CSA indicated. Acridine orange staining of (iv) larval or (v) prepupal midgut cells revealed positive nuclei (outlined in \[v\]) in prepupal cells. Blue, dotted lines mark trachea. (Bii--Biii) Mitochondria (green) in (ii) third-instar larval or (iii) prepupal salivary gland cells (outlined; A568 Phalloidin \[red\]). (Cii--Ciii) Mitochondria in wing disc cells (outlined) incubated for 2 hr with (iii) ecdysone or (ii) mock.\
(D--F) Mitochondrial morphology (green) and nuclear morphology (Hoechst-33342 \[D\]--\[F\]; red, dotted outline) in hemocytes incubated with (D) 10 μM etoposide, (E) 20 μM C~6~-ceramide, or (F) mock for indicated times. The nuclear CSA in the hemocyte shown is indicated. Top insets show cells positive for FITC-Annexin V (AnV, green) and PI (red) with highly condensed nuclei (Hoechst-33342; blue, dotted outline) at 10 hr.\
(G) Histogram showing the fraction of etoposide- or mock-treated (blue line) hemocytes (n = 100) with fragmented mitochondria (gray) or apoptotic nuclei (black) at specified times (mean ± SD; n = 2).\
(H) Nuclear CSA in etoposide- (black) or mock-treated (blue) hemocytes showed condensed nuclei (CSA \< 10 μm^2^) in AnV-positive cells (6 hr).\
(I) Histogram showing the number of C~6~-ceramide-treated hemocytes that had fragmented mitochondria at indicated times (mean ± SD; n = 2).\
Lower insets show a magnified view of the region marked with an asterisk. Arrows, arrowheads, and open arrowheads indicate tubular, fragmented, and extensively tubular mitochondria, respectively. The panel label of cells exposed to ecdysone, genotoxic stress, or ceramide has been outlined brown, orange, or pink, respectively.\
The scale bars in the panels are 5 μm; those in the top insets of the panel are 5 μm, and those in the lower insets are 2.5 μm.](gr1){#fig1}

![Mitochondrial Fragmentation Is Upstream of Effector Caspase Activation\
(A and B) (iii and vi) Phase-contrast and fluorescence images of (Aiv and Av) etoposide-, (Biv and Bv) C~6~-ceramide-, or (A and B) (i and ii) mock-treated hemocytes incubated with (i and iv) caspACE-FMK substrate or (ii and v) AnV (green), and PI (red) at the indicated times. Arrows indicate blebs.\
(C) Mitochondria (Mitotracker Red; green) and nuclei (\[ii--iii\] Hoechst-33342, \[I\] nuclear GFP; red, dotted outline) in (i) mock-, (ii) etoposide-, or (iii) C~6~-ceramide-treated *DIAP-1*+ (*Col-GAL4,UAS-GFP*; *UAS-DIAP-1*/+) hemocytes at indicated times. The nuclear CSA is indicated. Insets show a magnified view of the regions marked with an asterisk.\
(D and E) (i) Control and (ii and iii) *DIAP-1+* hemocytes incubated with (ii) etoposide or (i and iii) C~6~-ceramide stained for (D) active effector caspases or (E) AnV (green) and PI (red) positivity at indicated times.\
(F--H) (F and H) Histogram showing the fraction of (F) etoposide- or (H) C~6~-ceramide-treated *DIAP-1*+ hemocytes (n = 100) with fragmented mitochondria (gray) or apoptotic nuclei (black) at the indicated times (mean ± SD; n = 3). (G) Histogram showing the fraction of etoposide-treated mock or *DIAP-1*+ and 50 μM zVAD-fmk-treated hemocytes (n = 100) with apoptotic nuclei (mean ± SD; n = 3). ^∗∗^p \< 0.005.\
The scale bars in the panels are 5 μm; those in the insets are 2.5 μm.](gr2){#fig2}

![Mitochondrial Morphology Is Extensively Tubular in *drp-1* Mutants\
(A) *Drosophila* Drp-1 has an N-terminal GTPase domain, the middle domain, and a C-terminal GTPase effector domain. The mutations map to the GTPase domain.\
(B) Single-plane reconstruction of confocal images of mitochondria (Mitotracker Green) in (i) wild-type, (ii) *drp-1*^2^, (iii) *3665/13510*, and (iv) *13510/+* larval hemocytes.\
(C) Wide-field images of (i) *13510/+* and (ii) Dp/+; *13510/+* mitochondria.\
(D) Mitochondria (Mito-YFP) in (i) mock- or (ii) *drp-1* dsRNA-treated cells. Arrows, arrowheads, and open arrowheads indicate tubular, fragmented, and extensively tubular mitochondria, respectively. Insets show magnified views of areas marked with an asterisk.\
(E) RT-PCR showed reduced levels of *drp-1* RNA, not *Rp49* RNA, in *drp-1* dsRNA-treated cells.\
(F) FRAP of Mito-YFP measured in a defined mitochondrial region in mock- (black) or *drp-1* (gray) dsRNA-treated S2R^+^ cells showed increased recovery in *drp-1* dsRNA-treated cells (n = 35).\
The scale bars in the panels are 5 μm; those in the insets are 2.5 μm.](gr3){#fig3}

![PCD Is Suppressed in *drp-1* Mutants\
(A) Histogram showing the fraction of etoposide-treated wild-type (black) and *drp-1*^2^ (gray) hemocytes (n = 100) with apoptotic nuclei (CSA \< 10 μm^2^) at indicated times (mean ± SD; n = 3).\
(B and C) Histogram showing the fraction of (B) etoposide- or (C) cycloheximide-treated (0.5 μg/ml) wild-type, *3665/13510*, or *13510*/+ hemocytes (n = 100) with apoptotic nuclei (\[B\], mean ± propagated error; \[C\], mean ± SD; n = 3).\
(D) Histogram showing the number of surviving YFP-positive cells incubated for 5 days with either mock (black) or *drp-1* (gray) dsRNA and treated with cycloheximide and actinomycin-D (18 hr), normalized to the number of untreated cells.\
(E) Histogram showing the fraction of C~6~-ceramide-treated (10 hr) *drp-1*^2^ hemocytes (n = 100) with apoptotic nuclei, normalized to apoptotic wild-type cells (mean ± SD; n = 3).\
(F) (i, ii, v, and vi) Etoposide- or (iii, iv, vii, and viii) C~6~-ceramide-treated (i, iii, v, and vii) *drp-1*^2^ and (ii, iv, vi, and viii) *3665/13510* hemocytes stained for (i--iv) active effector caspases or (v--viii) AnV (green) and PI (red) accessibility.\
(G) Mitochondria (Mitotracker Green; green) and nuclei (Hoechst-33342; red, dotted outline) in etoposide-treated (i) wild-type, (ii) *drp-1*^2^, and (iii) *3665/13510* hemocytes showed a mitochondrial fragmentation defect and a block in nuclear condensation, as indicated by the nuclear CSA.\
(H) Mitochondria (anti-Biotin) in C~6~-ceramide-treated (i) *drp-1*^2^ and (ii and iii) *3665/13510* hemocytes at indicated times. The insets show magnified views of the regions marked with an asterisk. Arrows and arrowheads indicate tubular and fragmented mitochondria, respectively.\
(I) Optic lobes (OL) and ventral ganglion (VG) of the (i) wild-type or (ii) *drp-1*^2^ third-instar larval CNS. ^∗^p \< 0.05; ^∗∗^p \< 0.005. The scale bar is 100 μm in (I), 5 μm in all other panels, and 2.5 μm in all insets.\
(J) In *Drosophila*, multiple apoptotic stimuli such as ecdysone, genotoxic stresses, or C~6~-ceramide result in fragmentation (blue box) of elongated (red outline) mitochondria (green). Unlike with genotoxic stress, there is an increase in mitochondrial contiguity (purple outline) prior to its fragmentation during lipid-mediated cell death. Mitochondrial fragmentation mediated by Drp-1 (light-blue dots) upstream of effector caspase activation, PS exposure, nuclear condensation, and plasma membrane permeability affects cell death. Thus, mitochondrial remodeling modifies the susceptibility of cells to PCD.](gr4){#fig4}
